Ajooni Biotech Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajooni Biotech Limited has submitted a disclosure to NSE under Regulation 31(4) of SEBI Takeover Regulations. The company's promoters (along with persons acting in concert) have declared that they have NOT created any encumbrance or pledge over their shares during the financial year ended March 31, 2026. The disclosure is signed by Jasjot Singh, Managing Director, and includes details of the promoter group comprising Jasjot Singh, Parmjeet Kaur, Upneet Kaur, Ashmeet Kaur, and Ishneet Kaur.
This is a positive confirmation for investors as it indicates promoters have not borrowed against their shareholding, meaning their shares are unencumbered and not at risk of forced sale due to loan defaults.